Edition:
United Kingdom

Viking Therapeutics Inc (VKTX.OQ)

VKTX.OQ on NASDAQ Stock Exchange Capital Market

5.17USD
23 May 2018
Change (% chg)

$0.06 (+1.17%)
Prev Close
$5.11
Open
$5.14
Day's High
$5.17
Day's Low
$5.03
Volume
26,882
Avg. Vol
236,421
52-wk High
$7.34
52-wk Low
$0.88

Latest Key Developments (Source: Significant Developments)

Viking Therapeutics says Resale By Selling Stockholders Of Up To 2.6 Mln Shares
Wednesday, 20 Dec 2017 

Dec 20 (Reuters) - Viking Therapeutics Inc ::VIKING THERAPEUTICS - RESALE BY SELLING STOCKHOLDERS OF UP TO 2.6 MILLION SHARES OF CO'S COMMON STOCK - SEC FILING.  Full Article

Sphera Funds Management Ltd Reports 7.43 Pct Passive Stake In Viking Therapeutics
Monday, 18 Dec 2017 

Dec 18 (Reuters) - Viking Therapeutics Inc ::SPHERA FUNDS MANAGEMENT LTD REPORTS 7.43 PERCENT PASSIVE STAKE IN VIKING THERAPEUTICS INC AS OF DECEMBER 7 - SEC FILING.  Full Article

Viking Therapeutics Announces Closing Of Public Offering
Monday, 11 Dec 2017 

Dec 11 (Reuters) - Viking Therapeutics Inc ::VIKING THERAPEUTICS ANNOUNCES CLOSING OF PUBLIC OFFERING OF COMMON STOCK.  Full Article

Viking Therapeutics Announces Pricing Of $12.8 Million Public Offering Of Common Stock
Thursday, 7 Dec 2017 

Dec 6 (Reuters) - Viking Therapeutics Inc ::VIKING THERAPEUTICS ANNOUNCES PRICING OF $12.8 MILLION PUBLIC OFFERING OF COMMON STOCK.VIKING THERAPEUTICS INC- ‍ANNOUNCED PRICING OF ITS PUBLIC OFFERING OF 5,130,435 SHARES OF ITS COMMON STOCK AT A PRICE TO PUBLIC OF $2.50 PER SHARE​.  Full Article

Viking Therapeutics Announces Proposed Public Offering Of Common Stock
Tuesday, 5 Dec 2017 

Dec 5 (Reuters) - Viking Therapeutics Inc ::VIKING THERAPEUTICS ANNOUNCES PROPOSED PUBLIC OFFERING OF COMMON STOCK.VIKING THERAPEUTICS - INTENDS TO USE NET PROCEEDS FROM STOCK OFFERING FOR CONTINUED DEVELOPMENT OF ITS VK5211, VK2809 AND VK0214 PROGRAMS.  Full Article

Viking Therapeutics reports third quarter 2017 financial results
Wednesday, 8 Nov 2017 

Nov 8 (Reuters) - Viking Therapeutics Inc :Viking Therapeutics reports third quarter 2017 financial results and provides corporate update.Q3 loss per share $0.22.Q3 earnings per share view $-0.20 -- Thomson Reuters I/B/E/S.  Full Article

Viking Therapeutics files for sale of up to 6.9 mln shares by selling stockholder
Tuesday, 17 Oct 2017 

Oct 17 (Reuters) - Viking Therapeutics Inc :Viking Therapeutics Inc files for sale of up to 6.9 million shares of co's common stock by selling stockholder Lincoln Park Capital Fund Llc‍‍​ - SEC filing.  Full Article

Viking Therapeutics files for common stock offering of up to 7.5 mln shares
Friday, 2 Sep 2016 

Viking Therapeutics Inc : Files for common stock offering of up to 7.5 million shares of common stock by the selling stockholder aspire capital - SEC filing Source: (http://bit.ly/2c1blgi) Further company coverage: [VKTX.O] ((bangalore.newsroom@thomsonreuters.com;)).  Full Article

Viking Therapeutics reported Q2 EPS ($0.22)
Wednesday, 10 Aug 2016 

Viking Therapeutics Inc : Q2 loss per share $0.22 . Viking Therapeutics reports second quarter 2016 financial results and provides corporate update .Q2 earnings per share view $-0.20 -- Thomson Reuters I/B/E/S.  Full Article

BRIEF-Viking Therapeutics Q1 Loss Per Share $0.08

* VIKING THERAPEUTICS REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE